Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00928772 · ClinicalTrials.gov registry record · Phase 4
Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety
A Phase 4 study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- Phase 4
- Development phase
- 115
- Enrollment target
NCT00928772 is a Phase 4 study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 115 participants.
The verdict
NCT00928772, a Phase 4 study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 115 participants
- Enrollment target
Study Summary
Cranial electro stimulation (CES) provides safe, adequate, side-effect free sedation without excessive drowsiness in preoperative settings.
Interventions
- DEVICE CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM
- DRUG MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY
- OTHER NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00928772
The ClinicalTrials.gov registry entry for NCT00928772 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM is the first listed.
NCT00928772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00928772 about?
NCT00928772 is a clinical study titled "Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety". Cranial electro stimulation (CES) provides safe, adequate, side-effect free sedation without excessive drowsiness in preoperative settings.
What is the current status of trial NCT00928772?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 115 participants. The study started on 2009-07. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00928772?
The interventions under investigation include: CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM (DEVICE), MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY (DRUG), NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED (OTHER).
Who is sponsoring clinical trial NCT00928772?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.